Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies
- PMID: 12682272
- DOI: 10.4049/jimmunol.170.8.4349
Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies
Abstract
The advent in recent years of the application of tetrameric arrays of class I peptide-MHC complexes now enables us to detect and study rare populations of Ag-specific CD8(+) T cells. However, available methods cannot visualize or determine the number and distribution of these TCR ligands on individual cells nor detect APCs in tissues. In this study, we describe for the first time studies of human class I peptide-MHC ligand presentation. These studies were facilitated by applying novel tools in the form of peptide-specific, HLA-A2-restricted human recombinant Abs directed toward a viral epitope derived from human T cell lymphotropic virus type I. Using a large human Ab phage display library, we isolated a large panel of recombinant Fab Abs that are specific for a particular peptide-MHC class I complex in a peptide-dependent, MHC-restricted manner. We used these Abs to visualize the specific complex on APCs and virus-infected cells by flow cytometry, to quantify the number of, and visualize in situ, a particular complex on the surface of APCs bearing complexes formed by naturally occurring active intracellular processing of the cognate viral Ag. These findings demonstrate our ability to transform the unique fine specificity, but low intrinsic affinity of TCRs into high affinity soluble Ab molecules endowed with a TCR-like specificity toward human viral epitopes. These molecules may prove to be crucial useful tools for studying MHC class I Ag presentation in health and disease as well as for therapeutic purposes in cancer, infectious diseases, and autoimmune disorders.
Similar articles
-
Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.J Mol Recognit. 2003 Sep-Oct;16(5):324-32. doi: 10.1002/jmr.640. J Mol Recognit. 2003. PMID: 14523945 Review.
-
Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.J Immunol. 2003 Sep 15;171(6):3064-74. doi: 10.4049/jimmunol.171.6.3064. J Immunol. 2003. PMID: 12960332
-
Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.J Immunol. 2003 Sep 1;171(5):2197-207. doi: 10.4049/jimmunol.171.5.2197. J Immunol. 2003. PMID: 12928363
-
Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.Cancer Res. 2002 Jun 1;62(11):3184-94. Cancer Res. 2002. PMID: 12036932
-
Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation.Autoimmun Rev. 2006 Apr;5(4):252-7. doi: 10.1016/j.autrev.2005.07.004. Epub 2005 Aug 8. Autoimmun Rev. 2006. PMID: 16697965 Review.
Cited by
-
T Cell Receptor Engineering and Analysis Using the Yeast Display Platform.Methods Mol Biol. 2015;1319:95-141. doi: 10.1007/978-1-4939-2748-7_6. Methods Mol Biol. 2015. PMID: 26060072 Free PMC article.
-
TCR-like antibodies in cancer immunotherapy.J Hematol Oncol. 2019 Sep 14;12(1):99. doi: 10.1186/s13045-019-0788-4. J Hematol Oncol. 2019. PMID: 31521180 Free PMC article. Review.
-
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment.PLoS One. 2012;7(8):e43746. doi: 10.1371/journal.pone.0043746. Epub 2012 Aug 20. PLoS One. 2012. PMID: 22916301 Free PMC article.
-
A frameshift-generated cancer neoepitope that controls tumor burden in prophylaxis as well as therapy.J Immunol. 2025 Jun 1;214(6):1123-1132. doi: 10.1093/jimmun/vkaf016. J Immunol. 2025. PMID: 40209093 Free PMC article.
-
Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.Clin Exp Immunol. 2005 Dec;142(3):454-60. doi: 10.1111/j.1365-2249.2005.02929.x. Clin Exp Immunol. 2005. PMID: 16297157 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous